Tag: Biopharmaceutical industry
Summit Therapeutics Clinical Trial Update: What You Need to Know
Adam Feuerstein, a seasoned writer and biotech columnist, dives into the world of drug development, business, Wall Street, and biotechnology. He wears many hats...
Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets
Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in...
BREAKING NEWS
FDA Considers PDUFA Changes and Compounded Weight Loss Drugs
It's a beautiful morning at the Pharmalot campus, where the sun is shining, and a gentle breeze is blowing. The short person is still...
